Skip to Content

Teaching Hospitals

Coverage and Delivery Reform | GME | Hospital Payment and Quality | Patient Care Quality

Millions of Americans turn to teaching hospitals for specialized surgeries, life-saving care, and complex treatments. Teaching hospitals serve critical and unique community services, such as trauma and burn centers. These institutions are leaders in developing new cures and treatments and are continually improving medical education for future physicians. They are the training ground for more than 100,000 new physicians and other health professionals each year. And they are a vital part of America's safety net, providing care to millions of the country’s uninsured population.

The AAMC represents the nation's nearly 400 major teaching hospitals and health systems and their associated clinical physicians. AAMC members operate:

  • 79 percent of all level-one trauma centers;
  • 68 percent of all burn care unit beds,
  • 37 percent of neonatal ICUs
  • 59 percent of pediatric ICUs
  • 37 percent of all hospital charity care nationwide

(FY 2012 data, released December 2013)


New Teaching Hospital Resources

PQRS Overview

March 29, 2016

Overview of the Physician Quality Reporting System


SGR Repeal Webinar

April 17, 2015

Slides for the AAMC's webinar on repeal of the SGR


FY 2015 IPPS Quality Slides

June 2, 2014

Slides for the AAMC's webinar on the FY 2015 IPPS Proposed Rule


PQRS Overview

March 29, 2016

Overview of the Physician Quality Reporting System


SGR Repeal Webinar

April 17, 2015

Slides for the AAMC's webinar on repeal of the SGR


FY 2015 IPPS Quality Slides

June 2, 2014

Slides for the AAMC's webinar on the FY 2015 IPPS Proposed Rule


News and Updates


MedPAC Releases March 2019 Report to Congress, Recommends Payment Updates for Medicare’s Payment Systems

March 22, 2019

The Medicare Payment Advisory Commission (MedPAC) March 15 released its March 2019 Report to Congress. The report recommends payment updates for Medicare’s payment systems, including a 2% update for hospital inpatient and outpatient services.


MACPAC Releases March 2019 Report to Congress, Including Recommendation for DSH Allotments to States

March 22, 2019

The Medicaid and CHIP (Children’s Health Insurance Program) Payment and Access Commission (MACPAC) March 15 released its March 2019 Report to Congress on Medicaid and CHIP. The Commission made recommendations on restructuring disproportionate share hospital (DSH) allotment reductions in current law and upper payment limit (UPL) oversight. Additionally, MACPAC included its annual analysis of DSH allotments to states.


House Subcommittee Holds Legislative Hearing on Drug Pricing Proposals

March 15, 2019

The House Energy and Commerce Health Subcommittee March 13 held a legislative hearing to examine seven bills aimed at lowering the cost of prescription drugs and reducing barriers to market competition.


On Patient Care



Latest Testimony and Correspondence

MedPAC Releases March 2019 Report to Congress, Recommends Payment Updates for Medicare’s Payment Systems

March 22, 2019

The Medicare Payment Advisory Commission (MedPAC) March 15 released its March 2019 Report to Congress. The report recommends payment updates for Medicare’s payment systems, including a 2% update for hospital inpatient and outpatient services.


MACPAC Releases March 2019 Report to Congress, Including Recommendation for DSH Allotments to States

March 22, 2019

The Medicaid and CHIP (Children’s Health Insurance Program) Payment and Access Commission (MACPAC) March 15 released its March 2019 Report to Congress on Medicaid and CHIP. The Commission made recommendations on restructuring disproportionate share hospital (DSH) allotment reductions in current law and upper payment limit (UPL) oversight. Additionally, MACPAC included its annual analysis of DSH allotments to states.


House Subcommittee Holds Legislative Hearing on Drug Pricing Proposals

March 15, 2019

The House Energy and Commerce Health Subcommittee March 13 held a legislative hearing to examine seven bills aimed at lowering the cost of prescription drugs and reducing barriers to market competition.